Henry Schein, Inc. (HSIC) Shares Sold by New Mexico Educational Retirement Board
New Mexico Educational Retirement Board decreased its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 7.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,400 shares of the company’s stock after selling 600 shares during the period. New Mexico Educational Retirement Board’s holdings in Henry Schein were worth $1,348,000 as of its most recent SEC filing.
A number of other large investors also recently made changes to their positions in HSIC. Waldron LP bought a new stake in shares of Henry Schein during the first quarter valued at about $286,000. Mn Services Vermogensbeheer B.V. raised its stake in shares of Henry Schein by 2.0% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 2,147 shares of the company’s stock valued at $341,000 after buying an additional 43 shares during the last quarter. Candriam Luxembourg S.C.A. bought a new stake in shares of Henry Schein during the first quarter valued at about $207,000. Wagner Bowman Management Corp bought a new stake in shares of Henry Schein during the first quarter valued at about $222,000. Finally, State of Alaska Department of Revenue raised its stake in shares of Henry Schein by 264.7% in the first quarter. State of Alaska Department of Revenue now owns 23,597 shares of the company’s stock valued at $4,010,000 after buying an additional 17,126 shares during the last quarter. Institutional investors and hedge funds own 90.87% of the company’s stock.
Shares of Henry Schein, Inc. (HSIC) opened at 170.58 on Friday. The company has a market capitalization of $13.49 billion, a price-to-earnings ratio of 24.93 and a beta of 1.09. The company’s 50-day moving average is $181.54 and its 200-day moving average is $175.12. Henry Schein, Inc. has a 12-month low of $146.23 and a 12-month high of $186.99.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, August 8th. The company reported $1.75 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.73 by $0.02. The company had revenue of $3.06 billion during the quarter, compared to the consensus estimate of $3.05 billion. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. Henry Schein’s revenue was up 6.4% on a year-over-year basis. During the same period last year, the company earned $1.64 earnings per share. Analysts predict that Henry Schein, Inc. will post $7.28 EPS for the current year.
Several brokerages have issued reports on HSIC. Piper Jaffray Companies began coverage on shares of Henry Schein in a research report on Monday, June 12th. They set a “neutral” rating and a $200.00 target price for the company. Jefferies Group LLC reiterated a “hold” rating and set a $177.00 target price on shares of Henry Schein in a research report on Friday, July 21st. Zacks Investment Research lowered shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Friday, June 23rd. Credit Suisse Group reiterated a “hold” rating and set a $160.00 target price on shares of Henry Schein in a research report on Thursday, July 13th. Finally, Stifel Nicolaus restated a “hold” rating on shares of Henry Schein in a report on Thursday, July 6th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and seven have issued a buy rating to the company. Henry Schein currently has a consensus rating of “Hold” and an average price target of $185.56.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.